Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Charles M. Perou Mehra Golshan Deborah Collyar George Somlo Timothy J Pluard Jennifer R Bellon Sara M Tolaney Constance T Cirrincione Clifford A Hudis Eric Winer |
| Publication date | August 4, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |